AFT Pharmaceuticals Limited AFT.NZ Stock
AFT Pharmaceuticals Limited Price Chart
AFT Pharmaceuticals Limited AFT.NZ Financial and Trading Overview
AFT Pharmaceuticals Limited stock price | 3.15 NZD |
Previous Close | 3.5 NZD |
Open | 3.46 NZD |
Bid | 3.49 NZD x 372000 |
Ask | 3.6 NZD x 575400 |
Day's Range | 3.46 - 3.49 NZD |
52 Week Range | 3.18 - 4.08 NZD |
Volume | 24.1K NZD |
Avg. Volume | 29.71K NZD |
Market Cap | 365.98M NZD |
Beta (5Y Monthly) | 0.244061 |
PE Ratio (TTM) | 34.899998 |
EPS (TTM) | 0.1 NZD |
Forward Dividend & Yield | 0.01 (0.30%) |
Ex-Dividend Date | June 16, 2023 |
1y Target Est | 4.17 NZD |
AFT.NZ Valuation Measures
Enterprise Value | 400.33M NZD |
Trailing P/E | 34.899998 |
Forward P/E | 15.173913 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.3364403 |
Price/Book (mrq) | 4.992847 |
Enterprise Value/Revenue | 2.556 |
Enterprise Value/EBITDA | 20.138 |
Trading Information
AFT Pharmaceuticals Limited Stock Price History
Beta (5Y Monthly) | 0.244061 |
52-Week Change | -7.40% |
S&P500 52-Week Change | 20.43% |
52 Week High | 4.08 NZD |
52 Week Low | 3.18 NZD |
50-Day Moving Average | 3.53 NZD |
200-Day Moving Average | 3.59 NZD |
AFT.NZ Share Statistics
Avg. Volume (3 month) | 29.71K NZD |
Avg. Daily Volume (10-Days) | 16.14K NZD |
Shares Outstanding | 104.87M |
Float | 28.18M |
Short Ratio | N/A |
% Held by Insiders | 73.81% |
% Held by Institutions | 5.61% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.011 |
Trailing Annual Dividend Yield | 0.31% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | 6.80% |
Operating Margin (ttm) | 12.55% |
Gross Margin | 46.59% |
EBITDA Margin | 12.69% |
Management Effectiveness
Return on Assets (ttm) | 8.92% |
Return on Equity (ttm) | 15.71% |
Income Statement
Revenue (ttm) | 156.64M NZD |
Revenue Per Share (ttm) | 1.49 NZD |
Quarterly Revenue Growth (yoy) | 21.50% |
Gross Profit (ttm) | 72.98M NZD |
EBITDA | 19.88M NZD |
Net Income Avi to Common (ttm) | 10.65M NZD |
Diluted EPS (ttm) | 0.1 |
Quarterly Earnings Growth (yoy) | -41.00000000000000000000000000000000% |
Balance Sheet
Total Cash (mrq) | 4.75M NZD |
Total Cash Per Share (mrq) | 0.05 NZD |
Total Debt (mrq) | 38.05M NZD |
Total Debt/Equity (mrq) | 51.93 NZD |
Current Ratio (mrq) | 2.378 |
Book Value Per Share (mrq) | 0.699 |
Cash Flow Statement
Operating Cash Flow (ttm) | 11.63M NZD |
Levered Free Cash Flow (ttm) | -4966500 NZD |
Profile of AFT Pharmaceuticals Limited
Country | New Zealand |
State | N/A |
City | Auckland |
Address | 129 Hurstmere Road |
ZIP | 0622 |
Phone | 64 9 488 0232 |
Website | https://www.aftpharm.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 100 |
AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, nail care, oral care, pain management, skin care, and supplements, as well as other products. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.
Q&A For AFT Pharmaceuticals Limited Stock
What is a current AFT.NZ stock price?
AFT Pharmaceuticals Limited AFT.NZ stock price today per share is 3.15 NZD.
How to purchase AFT Pharmaceuticals Limited stock?
You can buy AFT.NZ shares on the NZSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for AFT Pharmaceuticals Limited?
The stock symbol or ticker of AFT Pharmaceuticals Limited is AFT.NZ.
Which industry does the AFT Pharmaceuticals Limited company belong to?
The AFT Pharmaceuticals Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does AFT Pharmaceuticals Limited have in circulation?
The max supply of AFT Pharmaceuticals Limited shares is 104.87M.
What is AFT Pharmaceuticals Limited Price to Earnings Ratio (PE Ratio)?
AFT Pharmaceuticals Limited PE Ratio is 31.50000000 now.
What was AFT Pharmaceuticals Limited earnings per share over the trailing 12 months (TTM)?
AFT Pharmaceuticals Limited EPS is 0.1 NZD over the trailing 12 months.
Which sector does the AFT Pharmaceuticals Limited company belong to?
The AFT Pharmaceuticals Limited sector is Healthcare.
AFT Pharmaceuticals Limited AFT.NZ included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
S&P/NZX ALL INDEX ( CAPITAL IND NZCI | 1769.77 NZD 1092.11 USD |
-0.5
|
— — | 1758.03 NZD 1084.87 USD | 1778.58 NZD 1097.55 USD | — - | — — |
S&P/NZX SMALLCAP INDEX ( CAPITA NZSC | 17512.45 NZD 10806.82 USD |
-0.61
|
— — | 17485.92 NZD 10790.45 USD | 17620.54 NZD 10873.52 USD | — - | — — |
- {{ link.label }} {{link}}